DUBLIN, Mar 22, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Transdermal Patch Market & Clinical Pipeline Outlook 2022" report to their offering.
Global Transdermal Patch Market & Clinical Pipeline Outlook 2022 report discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market. Report highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies. Currently there 40 transdermal patches available in the market and more than 70 patches are in clinical pipeline.
Transdermal patches have made their place in global market in past few decades as an alternative to conventional therapeutic for various disease indications. Systemic drug delivery could be achieved by oral and prenatal methods but they have several limitations due to which many patients often find them inconvenient. Pharmaceutical companies have identified these problems as an opportunity to develop transdermal patches for generating significant revenues. This problem was identified early and advancements in biotechnology helped in the introduction of transdermal patches in global market. Nowadays, they are available for different disease indications and generally found suitable for large number of people having different disease indications. As a result, numbers of users are escalating at tremendous rates which are steadily increasing the global size.
Transdermal patches are widely accepted among physicians and patients due to their non-invasive, pain free and easy administration. In recent years, the growth of transdermal patch market has increased and expected to increase significantly in coming years. Higher investments in research and development could be attributed to the success of transdermal patch market. Number of disease indication treated by them is increasing steadily leading to higher market penetration. Every year various transdermal patches are introduced in globally leading to increased market size.
- 3M Pharmaceuticals
- ANI Pharmaceuticals
- Agile Therapeutics
- Antares Pharma
- Bayer HealthCare Pharmaceuticals
- Chase Pharmaceuticals
- Corium International
- DURECT Corporation
- Endo Pharmaceuticals
- Hisamitsu Pharmaceutical
- Immune Pharmaceuticals
- Imprimis Pharmaceuticals
- Ipsen Bioscience
- Johnson & Johnson
Key Topics Covered:
1. Introduction to Transdermal Patch
2. Classification of Transdermal Patches
3. Why There Exist Need for Transdermal Patches?
4. Mechanism of Transdermal Patch Drug Delivery
5. Transdermal Patch v/s Traditional Drug Delivery Methods
6. Global Transdermal Patch Market Outlook
7. Global Transdermal Patch Clinical Pipeline Overview
8. Global Transdermal Patch Market Dynamics
9. Global Transdermal Patch Market Future Prospects
10. Global Transdermal Patch Clinical Insight
11. Marketed Transdermal Patch Clinical Insight by Company, Indication & Phase
12. Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/pnkrs6/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets